- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 2.37M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.05M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.71M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.76M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.21M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.89M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.22M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.4M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.61M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.6M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 379.63K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.41M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$8.21 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$8.21 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $778.9K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.84M |
| Revenue | Q1 2025 · Mar 31, 2024 | $305.72K |